| 前收盘价格 | 25.87 |
| 收盘价格 | 25.79 |
| 成交量 | 2,127,736 |
| 平均成交量 (3个月) | 2,149,106 |
| 市值 | 2,805,826,304 |
| 价格/销量 (P/S) | 195.72 |
| 股市价格/股市净资产 (P/B) | 9.98 |
| 52周波幅 | |
| 利润日期 | 6 Nov 2025 |
| 营业利益率 (TTM) | -1,525.50% |
| 稀释每股收益 (EPS TTM) | -3.01 |
| 季度收入增长率 (YOY) | 184.40% |
| 总债务/股东权益 (D/E MRQ) | 1.55% |
| 流动比率 (MRQ) | 10.49 |
| 营业现金流 (OCF TTM) | -152.68 M |
| 杠杆自由现金流 (LFCF TTM) | -117.16 M |
| 资产报酬率 (ROA TTM) | -33.54% |
| 股东权益报酬率 (ROE TTM) | -69.21% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Immunome, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
1.1
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | -3.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 1.13 |
|
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 11.48% |
| 机构持股比例 | 83.28% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Ecor1 Capital, Llc | 30 Sep 2025 | 4,079,415 |
| Jefferies Financial Group Inc. | 30 Sep 2025 | 2,100,000 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 40.00 (Evercore ISI Group, 57.30%) | 购买 |
| 中 | 34.00 (33.70%) | |
| 低 | 31.00 (Wedbush, 21.90%) | 购买 |
| 平均值 | 34.50 (35.67%) | |
| 总计 | 6 购买 | |
| 平均价格@调整类型 | 21.62 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wedbush | 15 Jan 2026 | 31.00 (21.90%) | 购买 | 22.85 |
| Evercore ISI Group | 16 Dec 2025 | 40.00 (57.29%) | 购买 | 23.48 |
| Guggenheim | 16 Dec 2025 | 35.00 (37.63%) | 购买 | 23.48 |
| Lake Street | 16 Dec 2025 | 32.00 (25.84%) | 购买 | 23.48 |
| Truist Securities | 01 Dec 2025 | 36.00 (41.57%) | 购买 | 18.32 |
| Stephens & Co. | 17 Nov 2025 | 33.00 (29.77%) | 购买 | 18.13 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合